Ultravate Lotion
Generic name:halobetasol propionate
Dosage form: lotion
Drug class:Topical steroids
Medically reviewed by Drugs.com. Last updated on Sep 1, 2020.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Ultravate Lotion
Ultravate Lotion is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older.
Ultravate Lotion Dosage and Administration
Apply a thin layer of Ultravate Lotion to the affected skin twice daily for up to two weeks. Rub in gently.
Discontinue therapy when control is achieved. If no improvement is seen within two weeks, reassessment of diagnosis may be necessary.
Treatment beyond two weeks is not recommended and the total dosage should not exceed 50 grams (50 ml) per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis [see Warnings and Precautions (5.1)]. Do not use with occlusive dressings unless directed by a physician.
Ultravate Lotion is for external use only.
Avoid use on the face, scalp, groin, or axillae.
Ultravate Lotion is not for ophthalmic, oral, or intravaginal use.
Dosage Forms and Strengths
ULTRAVATE (halobetasol propionate) lotion, 0.05% is a white to off-white lotion. Each gram of Ultravate Lotion contains 0.5 mg of halobetasol propionate.
Contraindications
None.
Warnings and Precautions
Effects on Endocrine System
Ultravate Lotion has been shown to suppress the hypothalamic-pituitary-adrenal (HPA) axis.
Systemic effects of topical corticosteroids may include reversible HPA axis suppression, with the potential for glucocorticosteroid insufficiency. This may occur during treatment or upon withdrawal of treatment of the topical corticosteroid.
Th...